ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625985 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625985; 2) Community: the network communities that were significantly associated with the response to NSC 625985; 3) Molecule: the relationships between components within communities and NSC 625985; 4) MDR: the compounds that were significantly associated with the NSC 625985.

NSC Compound Enrichment Correlation
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0139289274573436 0.67245502
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0139289274573436 0.69902878
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0139289274573436 0.78269221
NSC 330512 GELDANAMYCIN, N,N'-DIMETHYL 0.0145667015252499 0.67982575
NSC 38535 2,6-Bis(4-morpholinylmethyl)cyclohexanone,dihydrochloride 0.0145667015252499 0.61393783
NSC 645998 Null 0.01456670152525 0.78975791
NSC 670786 Null 0.01456670152525 0.57623349
NSC 680410 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester (9CI) 0.01456670152525 0.56508766
NSC 687011 stereoisomer of 672120 (MW=262) 0.01456670152525 0.70704054
NSC 145669 4(1H)-Quinazolinone, 2,3-dihydro-2-(1-naphthalenyl)- (9CI) 0.0154796321991294 0.17924579
Total:59  Current:18    [First] [Prev] [Next] [Last]